Abstract
Background
Transjugular intrahepatic portosystemic shunt (TIPS) has proven clinical efficacy as rescue therapy for cirrhotic patients with acute portal hypertensive bleeding who fail endoscopic treatment.
Aims
To investigate predictive factors of 6-week and 1-year mortality in patients undergoing salvage TIPS for refractory portal hypertensive bleeding.
Methods
A total of 144 consecutive patients were retrospectively evaluated. Three logistic regression multivariate models were estimated to individualize prognostic factors for 6-week and 12-month mortality. Log-rank test was used to evaluate survival according to Child–Pugh classes and Bureau’s criteria.
Results
Mean age 51 ± 10 years, 66% male, mean MELD 18.5 ± 8.3, Child–Pugh A/B/C 8%/38%/54%. TIPS failure occurred in 23(16%) patients and was associated with pre-TIPS portal pressure gradient and pre-TIPS intensive care unit stay. Six-week and 12-month mortality was 36% and 42%, respectively. Pre-TIPS intensive care unit stay, MELD, and Child–Pugh score were independently associated with mortality at 6 weeks. Independent predictors of mortality at 12 months were pre-TIPS intensive care unit stay and Child–Pugh score.
Conclusions
In this large cohort of patients undergoing salvage TIPS, MELD and Child–Pugh scores were predictive of short- and long-term mortality, respectively. Pre-TIPS intensive care unit stay was independently associated with TIPS failure and mortality at 6 weeks and 12 months. Salvage TIPS is futile in patients with Child–Pugh score of 14–15.
Similar content being viewed by others
Abbreviations
- TIPS:
-
Transjugular intrahepatic portosystemic shunt
- PTFE:
-
Polytetrafluoroethylene
- MELD:
-
Model for end-stage liver disease
- PHB:
-
Portal hypertensive bleeding
- INR:
-
International normalized ratio
- AST:
-
Aspartate aminotransferase
- ALT:
-
Alanine aminotransferase
- CPS:
-
Child–Pugh score
- PPG:
-
Portal pressure gradient
- RBCs:
-
Number of blood units transfused
- ITUs:
-
Length of intensive care unit stay
- MV:
-
Mechanical ventilation
- HE:
-
Hepatic encephalopathy
- OR:
-
Odds ratio
- 95% CI:
-
95% confidence interval
- NAFLD:
-
Nonalcoholic fatty liver disease
- AI:
-
Autoimmune
- EV:
-
Esophageal varices
- GV:
-
Gastric varices
- OLT:
-
Orthotopic liver transplant
- Na:
-
Sodium
- PLTs:
-
Platelets
- Hb:
-
Hemoglobin
- WBCs:
-
White blood cells
References
Richter GM, Noeldge G, Palmaz JC, Roessle M. The transjugular intrahepatic portosystemic stent-shunt (TIPSS): results of a pilot study. Cardiovasc Interv Radiol. 1990;13:200–207.
Conn HO, Resnick RH, Grace ND, et al. Distal splenorenal shunt vs. portal-systemic shunt: current status of a controlled trial. Hepatology. 1981;1:151–160.
Garcia-Pagan JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362:2370–2379.
Rossle M, Ochs A, Gulberg V, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med. 2000;342:1701–1707.
Tsochatzis EA, Gerbes AL. Diagnosis and treatment of ascites. J Hepatol. 2017;67:184–185.
Rossle M. TIPS: 25 years later. J Hepatol. 2013;59:1081–1093.
Bhogal HK, Sanyal AJ. Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis. Clin Gastroenterol Hepatol. 2011;9:936–946. (quiz e123).
Tripathi D, Redhead D. Transjugular intrahepatic portosystemic stent-shunt: technical factors and new developments. Eur J Gastroenterol Hepatol. 2006;18:1127–1133.
Patidar KR, Sydnor M, Sanyal AJ. Transjugular intrahepatic portosystemic shunt. Clin Liver Dis. 2014;18:853–876.
Rouillard SS, Bass NM, Roberts JP, et al. Severe hyperbilirubinemia after creation of transjugular intrahepatic portosystemic shunts: natural history and predictors of outcome. Ann Intern Med. 1998;128:374–377.
Angermayr B, Cejna M, Koenig F, et al. Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents. Hepatology. 2003;38:1043–1050.
Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–871.
Casadaban LC, Parvinian A, Zivin SP, et al. MELD score for prediction of survival after emergent TIPS for acute variceal hemorrhage: derivation and validation in a 101-patient cohort. Ann Hepatol. 2015;14:380–388.
Bureau C, Metivier S, D’Amico M, et al. Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS. J Hepatol. 2011;54:901–907.
Azoulay D, Castaing D, Majno P, et al. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol. 2001;35:590–597.
de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43:167–176.
Patch D, Nikolopoulou V, McCormick A, et al. Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatol. 1998;28:454–460.
Martin M, Zajko AB, Orons PD, et al. Transjugular intrahepatic portosystemic shunt in the management of variceal bleeding: indications and clinical results. Surgery. 1993;114:719–726. (discussion 26–27).
DiSalle RS, Dolmatch BL. Treatment of TIPS stenosis with ePTFE graft-covered stents. Cardiovasc Interv Radiol. 1998;21:172–175.
Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology. 2004;40:793–801.
Bernard B, Cadranel JF, Valla D, Escolano S, Jarlier V, Opolon P. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology. 1995;108:1828–1834.
Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383:1749–1761.
de Franchis R, Baveno VIF. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–752.
Hernandez-Gea V, Procopet B, Giraldez A, et al. Preemptive-TIPS improves outcome in high-risk variceal bleeding: an observational study. Hepatology. 2018. https://doi.org/10.1002/hep.30182.
Thabut D, Pauwels A, Carbonell N, et al. Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results. J Hepatol. 2017. https://doi.org/10.1016/j.jhep.2017.09.002.
Tripathi D, Stanley AJ, Hayes PC, et al. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut. 2015;64:1680–1704.
D’Amico G, D’Amico M, Malizia G. Refining early-TIPS criteria requires good quality prognostic studies. Liver Int. 2018;38:412–414.
Lopera JE. Role of emergency transjugular intrahepatic portosystemic shunts. Semin Interv Radiol. 2005;22:253–265.
Vangeli M, Patch D, Burroughs AK. Salvage tips for uncontrolled variceal bleeding. J Hepatol. 2002;37:703–704.
Chalasani N, Clark WS, Martin LG, et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology. 2000;118:138–144.
Yoon CJ, Chung JW, Park JH. Transjugular intrahepatic portosystemic shunt for acute variceal bleeding in patients with viral liver cirrhosis: predictors of early mortality. AJR. 2005;185:885–889.
Child CG. Remote results of portal surgery in liver cirrhosis. Revue internationale d’hepatologie. 1964;14:287–288.
Al-Freah MA, Gera A, Martini S, et al. Comparison of scoring systems and outcome of patients admitted to a liver intensive care unit of a tertiary referral centre with severe variceal bleeding. Aliment Pharmacol Ther. 2014;39:1286–1300.
Zhou C, Hou C, Cheng D, Tang W, Lv W. Predictive accuracy comparison of MELD and Child–Turcotte–Pugh scores for survival in patients underwent TIPS placement: a systematic meta-analytic review. Int J Clin Exp Med. 2015;8:13464–13472.
D’Amico G, Luca A, Morabito A, Miraglia R, D’Amico M. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology. 2005;129:1282–1293.
Patch D, Armonis A, Sabin C, et al. Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding. Gut. 1999;44:264–269.
Gines P, Fernandez J, Durand F, Saliba F. Management of critically-ill cirrhotic patients. J Hepatol. 2012;56:S13–S24.
Fichet J, Mercier E, Genee O, et al. Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy. J Crit Care. 2009;24:364–370.
Perarnau JM, Le Gouge A, Nicolas C, et al. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial. J Hepatol. 2014;60:962–968.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors who have taken part in this study do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.
Ethical approval
This was a single-center retrospective audit including consecutive patients with cirrhosis and variceal bleeding admitted at the Royal Free Hospital who underwent TIPS placement. As such, ethical approval and consent was not required.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Maimone, S., Saffioti, F., Filomia, R. et al. Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS). Dig Dis Sci 64, 1335–1345 (2019). https://doi.org/10.1007/s10620-018-5412-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-018-5412-x